US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

minolira

Reason CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

EPI Health, LLC NDC 71403-101-30 D-0474-2024
Class II · Moderate risk Terminated

Cloderm

Reason CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

EPI Health, LLC NDC 71403-804-90 D-0473-2024
Class III · Low risk Terminated

Cyclophosphamide for Injection

Reason Labeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Preparation, Handling, and Administration. The concentration of the reconstituted product is listed as '20 mg per vial.' This information should read: '20 mg per mL'.

X-Gen Pharmaceuticals Inc. NDC 39822-0255-01 D-0434-2024
Class III · Low risk Terminated

Cyclophosphamide for Injection

Reason Labeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Preparation, Handling, and Administration. The concentration of the reconstituted product is listed as '20 mg per vial.' This information should read: '20 mg per mL'.

X-Gen Pharmaceuticals Inc. NDC 39822-0250-01 D-0433-2024
Class II · Moderate risk Terminated

Eyesaline

Reason CGMP Deviations

Honeywell INC D-0461-2024
Class I · High risk Terminated

Atovaquone Oral Suspension USP

Reason Microbial contamination of a non-sterile product: potential Bacillus cereus contamination.

AvKARE NDC 50268-086-12 D-0444-2024
Class III · Low risk Terminated

Digoxin Tablets

Reason Failed Impurities/Degradation Specifications

Novitium Pharma LLC NDC 70954-200-10 D-0443-2024
Class II · Moderate risk Terminated

Lactated Ringer's Injection USP

Reason Lack of assurance of sterility: bags have the potential to leak..

B. Braun Medical Inc NDC 0264-7750-00 D-0431-2024
Class I · High risk Terminated

Vancomycin Hydrochloride for Oral Solution

Reason Superpotent Drug: Due to overfilling of drug powder

Amneal Pharmaceuticals of New York, LLC NDC 69238-2261-3 D-0442-2024
Class II · Moderate risk Terminated

Rifampin Capsules USP

Reason Subpotent Drug

Lupin Pharmaceuticals Inc. NDC 6818-0659-06 D-0437-2024
Class II · Moderate risk Terminated

VCF Vaginal Contraceptive Film

Reason cGMP Diviations

Apothecus Pharmaceutical Corp. NDC 52925-112-01 D-0427-2024
Class II · Moderate risk Terminated

Tri-Lo-Sprintec

Reason Failed Dissolution Specifications

Teva Pharmaceuticals USA, Inc NDC 0093-2140-62 D-0428-2024
Class II · Moderate risk Terminated

Potassium Chloride for Injection Concentrate USP

Reason Lack of assurance of sterility: pinholes, within the blue label characters on the EXCEL bag, specifically within the dotted characters on the label, resulting in leaks.

B. Braun Medical Inc NDC 0264-1944-20 D-0370-2024
Class II · Moderate risk Terminated

Betimol

Reason Lack of Assurance of Sterility: Out of specification for volume and compromised container closure.

Thea Pharma, Inc. NDC 82584-002-15 D-0374-2024
Class III · Low risk Terminated

Digoxin Tablets

Reason Cross Contamination with Other Products:(mycophenolate mofetil).

Novitium Pharma LLC NDC 70954-201-20 D-0389-2024
Class II · Moderate risk Terminated

Tobramycin for Injection

Reason Failed Stability Specification: Water determination was found not complying with specification.

Eugia US LLC NDC 55150-470-06 D-0385-2024
Class II · Moderate risk Terminated

PROBLEND Hand Sanitizer

Reason CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.

Seatex LLC D-0360-2024
Class II · Moderate risk Terminated

7 Eleven Hand Sanitizer Gel

Reason CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.

Seatex LLC D-0359-2024
Class II · Moderate risk Terminated

7 Eleven FOR GAS ISLAND USE ONLY

Reason CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.

Seatex LLC D-0358-2024
Class II · Moderate risk Terminated

PROBLEND E3 Foaming Hand Sanitizer

Reason CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.

Seatex LLC D-0357-2024
Class II · Moderate risk Terminated

Oseltamivir Phosphate for Oral Suspension 6mg/ml

Reason Failed Impurities/Degradation Specifications: Out-of-specification test results.

Amneal Pharmaceuticals of New York, LLC NDC 69238-1273-6 D-0327-2024